2017-06-302026-03-272017-06-302009Juan Carlos Bautista Ramírez0032-094310.1055/s-0029-1185319http://doi.org/10.1055/s-0029-1185319https://repositorio.inprf.gob.mx/handle/123456789/6166engacceso cerradoAnalgesics-ChemistryAnalgesics-PharmacologyAnalgesics-Therapeutic useAnimalsArthritis-Chemically inducedArthritis-Drug therapyChromatography, GasMaleMass SpectrometryNaloxone-PhamacologyNarcotic antagonists-PharmacologyOils, volatile-ChemistryOils, volatile-PhamacologyOils, volatile-Therapeutic usePain-Chemically inducedPain-Drug therapyPiperazines-PhamacologyPlant components, AerialPlant extracts-ChemistryPlant extracts-PhamacologyPlant extracts-Tharapeutic usePyridines-PharmacologyRatsRats, WistarRosmarinus-ChemistrySerotonin antagonists-PhamacologyTerpenes-Isolation & purificationUric acid-Adverse effectsAnalgesicsNarcotic antagonistsOils, volatilePiperazinesPlant extractsPyridinesSerotonin antagonistsTerpenesNaloxoneUric acidN-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamideAntinociceptive effect and GC/MS analysis of Rosmarinus officinalis L. essential oil from its aerial partsarticle1439-02215Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz508-511Alemania75AntinociceptionEndogenous opioidsPIFIR assay5 HT1A receptorsRosmarinus officinalis L.LamiaceaeAntinocicepciónOpioides endógenosEnsayo PIFIRReceptores 5 HT1ARosmarinus officinalis L.Lamiaceae